Filtered By:
Condition: Heart Failure
Countries: Spain Health

This page shows you your search results in order of relevance. This is page number 2.

Order by Relevance | Date

Total 149 results found since Jan 2013.

Cardiovascular diseases in people with diabetes mellitus in Spain according to the Primary Care Clinical Database (BDCAP) in 2017
CONCLUSIONS: This study shows the high cardiovascular comorbidity of patients with diabetes in Spain, with a greater excess of risk in patients under 65 years of age, more pronounced in women. We should offer more intensive treatment for DM2 in women.PMID:33810870 | DOI:10.1016/j.medcli.2020.12.040
Source: Medicina Clinica - April 3, 2021 Category: General Medicine Authors: Pedro Pujante Alarc ón Edelmiro Luis Men éndez Torre Paula Morales S ánchez Ra úl Rodríguez Escobedo Santiago Conde Barreiro Gemma Rojo Mart ínez El ías Delgado Alvarez autores en representaci ón del Grupo de Epidemiología de la Sociedad Español Source Type: research

Empagliflozin cardiovascular and renal effectiveness and safety compared to dipeptidyl peptidase-4 inhibitors across 11 countries in Europe and Asia: Results from the EMPagliflozin compaRative effectIveness and SafEty (EMPRISE) study
Diabetes Metab. 2023 Jan 3:101418. doi: 10.1016/j.diabet.2022.101418. Online ahead of print.ABSTRACTBACKGROUND: Continued expansion of indications for sodium-glucose cotransporter-2 inhibitors increases importance of evaluating cardiovascular and kidney efficacy and safety of empagliflozin in patients with type 2 diabetes compared to similar therapies.METHODS: The EMPRISE Europe and Asia study is a non-interventional cohort study using data from 2014-2019 in seven European (Denmark, Finland, Germany, Norway, Spain, Sweden, United Kingdom) and four Asian (Israel, Japan, South Korea, Taiwan) countries. Patients with type 2 d...
Source: Diabetes and Metabolism - January 7, 2023 Category: Endocrinology Authors: Avraham Karasik Stefanie Lanzinger Elise Chia-Hui Tan Daisuke Yabe Dae Jung Kim Wayne H-H Sheu Cheli Melzer-Cohen Reinhard W Holl Kyoung Hwa Ha Kamlesh Khunti Francesco Zaccardi Anuradhaa Subramanian Krishnarajah Nirantharakumar Thomas Nystr öm Leo Niska Source Type: research

Results of global fats and carbs study not very relevant for UK
Conclusion The results of the study have been presented in the media as if they overturn all current dietary guidelines. In the UK at least, that is completely misleading. The study results support the UK guidelines, having found that people who get around 50% of their calories from carbohydrates and 35% from fat, as recommended by Public Health England, were likely to live the longest. There are some limitations to the study, not least that observational studies cannot prove cause and effect. For example, the very low fat and high carbohydrate levels of diets found among some participants in the study might simply repres...
Source: NHS News Feed - August 30, 2017 Category: Consumer Health News Tags: Food/diet Source Type: news

Clinical profile and satisfaction with anticoagulated treatment in patients with non-valvular atrial fibrillation attended in Internal Medicine and Neurology departments of Spain.
CONCLUSIONS: Although there were some differences in the clinical profile of patients with atrial fibrillation attended in Neurology or Internal Medicine departments, all of them had many comorbidities and a high thromboembolic risk. Despite INR control was poor, the most common oral anticoagulant used were vitamin K antagonists. Satisfaction related to oral anticoagulation was high. PMID: 28990646 [PubMed - in process]
Source: Revista de Neurologia - October 12, 2017 Category: Neurology Tags: Rev Neurol Source Type: research

Medtronic touts reduced AF, improved activity in AdaptivCRT studies
Medtronic (NYSE:MDT) today released results from two real-world analyses of its AdaptivCRT algorithm, touting that its use was linked to a reduction in atrial fibrillation episodes and higher patient activity levels. Results from the analyses, which involved a total of 408 patients at 26 centers in Italy, were presented at the European Heart Rhythm Association’s Scientific Sessions 2018 in Barcelona, Spain, the company said. Medtronic’s AdaptivCRT algorithm is designed to adjust pacing to the heart dependent upon evaluations of heart rhythm made every minute, the company said. The program has been shown to in...
Source: Mass Device - March 20, 2018 Category: Medical Devices Authors: Fink Densford Tags: Cardiac Assist Devices Cardiac Implants Cardiovascular Clinical Trials Software / IT Medtronic Source Type: news

National trends in diabetes mellitus hospitalization in Spain 1997-2010: Analysis of over 5.4 millions of admissions.
CONCLUSIONS: Hospitalizations of diabetic patients more than doubled in Spain during the study period. Heart failure and neoplasms experienced the greatest annual increases and remained the principal causes of hospitalization, probably associated with advanced age and comorbidities of hospitalized diabetics. Coronary and cerebrovascular diseases experienced a lower annual increase, suggesting an improvement in cardiovascular care in diabetes in Spain. PMID: 30100217 [PubMed - as supplied by publisher]
Source: European Journal of Internal Medicine - August 9, 2018 Category: Internal Medicine Authors: Lara-Rojas CM, Pérez-Belmonte LM, López-Carmona MD, Guijarro-Merino R, Bernal-López MR, Gómez-Huelgas R Tags: Eur J Intern Med Source Type: research

Health care cost analysis of enhanced pacing modalities in bradycardia patients: Portuguese case study on the results of the MINERVA trial
ConclusionThe combination of atrial preventive pacing, atrial antitachycardia pacing and an algorithm to minimize the detrimental effect of right ventricular pacing reduces recurrent and permanent AF. The new DDDRP + MVP pacing mode could contribute to significant costs savings in the Portuguese health care setting.ResumoIntroduçãoObservamos no estudo MINERVA que a prevenção de pacing auricular e antitaquicardia (DDDRP), em combinação com algoritmos de redução de pacing ventricular (MVP), reduzem a fibrilhação auricular (FA) permanente em doentes com bradicardia, com FA permanente ou paroxística que necessitam d...
Source: Revista Portuguesa de Cardiologia - December 28, 2018 Category: Cardiology Source Type: research

Factors associated with development of nephrotoxicity in patients treated with vancomycin versus daptomycin for severe Gram-positive infections: A practice-based study.
CONCLUSIONS: Nephrotoxicity with VAN was significantly higher than with DAP despite poorer basal renal status in the DAP group. PMID: 30630306 [PubMed - as supplied by publisher]
Source: Revista Espanola de Quimioterapia - January 8, 2019 Category: Drugs & Pharmacology Authors: Barberan J, Mensa J, Artero A, Epelde F, Rodriguez JC, Ruiz-Morales J, Calleja JL, Guerra JM, Martínez-Gil I, Giménez MJ, Granizo JJ, Aguilar L Tags: Rev Esp Quimioter Source Type: research

Prevalence and outcomes of atrial fibrillation in a European healthcare area gained through the processing of a health information technology system
ConclusionsIn this study, we report for the first time the true prevalence of diagnosed AF and its clinical characteristics, treatment and prognosis in a Spanish healthcare area, based on the systematic integration of data available from a universally adopted health IT system within the region.ResumoIntroduçãoAs políticas dos cuidados de saúde confiam essencialmente em dados provenientes de múltiplos pequenos estudos no âmbito de populações diversificadas. Desejamos descrever a prevalência, as comorbilidades e os resultados da fibrilhação auricular (FA) numa população pertencente a uma área específica onde o...
Source: Revista Portuguesa de Cardiologia - February 28, 2019 Category: Cardiology Source Type: research

Cardiovascular Incomes In The Hypertensive And Diabetic Mediterranean Population Older Than 65 Years Old
Background and Aims: In Spain, hypertension and DM are major health problems. The importance of determining the CV risk associated with both is based on the evidence of simultaneous CV risk factors potentiate each other, giving rise to a total CV risk that is greater than the sum of its components. Our objective was to study the income from coronary heart disease, heart failure or stroke produced in these patients during follow-up.
Source: Atherosclerosis - August 4, 2019 Category: Cardiology Authors: B. Roig-Espert, J.J. Tamarit-Garc ía, A. González-Cruz-Cervellera, V. Pallarés-Carratalá, P. Morillas-Blasco Tags: Posters 26 - 29 May, 2019 Source Type: research